15-Year Study: Genotropin Enhances Growth and Quality of Life in SGA Males
Reading Time: 2 minutes Introduction Short stature can significantly impact an individual's quality of life, affecting not only physical health but also psychological well-being and social interactions. In the United States, a notable proportion of males born small for gestational age (SGA) face challenges associated with short stature. Genotropin, a recombinant human growth hormone, has been utilized to address growth deficiencies in this population. This article delves into a longitudinal study spanning 15 years, examining the efficacy of Genotropin in treating short stature in American males born SGA. Study Design and Methodology The study involved a cohort of 250 American males born SGA, who...


